Total Payments
$18,955
2024 Payments
$7,070
Companies
11
Transactions
77
Medicare Patients
6,170
Medicare Billing
$459,592
Payment Breakdown by Category
Food & Beverage$9,732 (51.3%)
Travel$4,773 (25.2%)
Other$2,450 (12.9%)
Research$2,000 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,732 | 45 | 51.3% |
| Travel and Lodging | $4,773 | 26 | 25.2% |
| Honoraria | $2,450 | 3 | 12.9% |
| Unspecified | $2,000 | 3 | 10.6% |
Payments by Type
General
$16,955
74 transactions
Research
$2,000
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AltaThera Pharmaceuticals LLC | $7,000 | 1 | $0 (2024) |
| Abbott Laboratories | $2,568 | 26 | $0 (2023) |
| Pfizer Inc. | $2,450 | 3 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $2,174 | 4 | $0 (2022) |
| ATRICURE, INC. | $1,663 | 15 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,648 | 16 | $0 (2019) |
| Biosense Webster, Inc. | $1,015 | 6 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $195.08 | 2 | $0 (2024) |
| Boston Scientific Corporation | $109.56 | 2 | $0 (2018) |
| Endologix, Inc. | $108.89 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,070 | 2 | AltaThera Pharmaceuticals LLC ($7,000) |
| 2023 | $1,422 | 13 | ATRICURE, INC. ($1,264) |
| 2022 | $3,087 | 17 | Abbott Laboratories ($1,426) |
| 2021 | $1,444 | 13 | SANOFI-AVENTIS U.S. LLC ($750.00) |
| 2020 | $2,800 | 4 | Pfizer Inc. ($2,450) |
| 2019 | $1,007 | 6 | Biosense Webster, Inc. ($520.89) |
| 2018 | $960.73 | 12 | Medtronic Vascular, Inc. ($534.29) |
| 2017 | $1,163 | 10 | Medtronic Vascular, Inc. ($1,061) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $70.08 | General |
| 02/24/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $7,000.00 | General |
| Category: Cardiovascular | ||||||
| 12/12/2023 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Electrophysiology | ||||||
| 09/22/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Travel and Lodging | In-kind items and services | $302.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $59.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $174.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $117.74 | General |
| Category: Cardiology | ||||||
| 04/18/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Travel and Lodging | In-kind items and services | $368.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $102.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $76.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/16/2023 | Biosense Webster, Inc. | OCTARAY MAPPING CATHETER (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diagnostic Catheters | ||||||
| 12/21/2022 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | — | In-kind items and services | $1,250.00 | Research |
| Study: Atrial fibrillation symptomology (2020 MC) • Category: Cardiology/Vascular Diseases | ||||||
| 10/12/2022 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: Electrophysiology | ||||||
| 06/08/2022 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Cardiology | ||||||
| 04/28/2022 | AtriCure, Inc. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $44.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/28/2022 | AtriCure, Inc. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/27/2022 | AtriCure, Inc. | SYNERGY ABLATION SYSTEM (Device) | Travel and Lodging | In-kind items and services | $199.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/27/2022 | AtriCure, Inc. | SYNERGY ABLATION SYSTEM (Device) | Travel and Lodging | In-kind items and services | $92.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/27/2022 | AtriCure, Inc. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/26/2022 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.67 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/02/2022 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $529.00 | General |
| Category: Cardiac Rhythm Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Atrial fibrillation symptomology (2020 MC) | SANOFI-AVENTIS U.S. LLC | $2,000 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,669 | 2,032 | $470,001 | $111,660 |
| 2022 | 27 | 1,548 | 1,978 | $477,227 | $123,376 |
| 2021 | 28 | 1,649 | 2,038 | $497,270 | $128,914 |
| 2020 | 28 | 1,304 | 1,659 | $363,316 | $95,643 |
Total Patients
6,170
Total Services
7,707
Medicare Billing
$459,592
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 33 | 33 | $121,673 | $23,930 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 133 | 162 | $51,824 | $16,286 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 131 | 173 | $40,958 | $11,589 | 28.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 34 | 45 | $62,135 | $10,672 | 17.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 23 | 23 | $35,074 | $8,617 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 83 | $26,377 | $8,609 | 32.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 44 | $10,111 | $4,099 | 40.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 541 | 667 | $13,847 | $3,960 | 28.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $11,287 | $3,306 | 29.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 140 | 141 | $9,016 | $2,790 | 31.0% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 11 | 11 | $15,185 | $2,609 | 17.2% |
| 93623 | Programming of heart rhythm stimulation after drug infusion | Facility | 2023 | 41 | 41 | $21,400 | $2,586 | 12.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 83 | 120 | $10,106 | $2,262 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $5,451 | $1,695 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,309 | $1,144 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $4,648 | $1,139 | 24.5% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 33 | 37 | $3,662 | $984.64 | 26.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 47 | 47 | $3,005 | $930.13 | 31.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 29 | 39 | $6,360 | $843.82 | 13.3% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 37 | 37 | $2,332 | $675.86 | 29.0% |
| 93286 | Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | Facility | 2023 | 33 | 66 | $2,441 | $673.24 | 27.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 92 | 97 | $2,014 | $539.24 | 26.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 28 | 33 | $1,823 | $494.45 | 27.1% |
| 93287 | Programming of single, dual or multiple lead implantable defibrillator system before or after surgery | Facility | 2023 | 16 | 26 | $1,429 | $447.02 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $1,706 | $431.02 | 25.3% |
About Dr. Thomas Bunch, M.D
Dr. Thomas Bunch, M.D is a Cardiovascular Disease healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790757516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Bunch, M.D has received a total of $18,955 in payments from pharmaceutical and medical device companies, with $7,070 received in 2024. These payments were reported across 77 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($9,732).
As a Medicare-enrolled provider, Bunch has provided services to 6,170 Medicare beneficiaries, totaling 7,707 services with total Medicare billing of $459,592. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Rochester, MN
- Active Since 02/06/2006
- Last Updated 11/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790757516
Products in Payments
- Sotalol Hydrochloride (Drug) $7,000
- MULTAQ (Drug) $2,174
- ELIQUIS (Drug) $1,750
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $1,264
- AVEIR (Device) $1,026
- Micra (Device) $928.60
- SYNERGY ABLATION SYSTEM (Device) $399.23
- Ensite Cardiac Mapping System (Device) $178.42
- ENSITE (Device) $140.94
- Reveal LINQ (Device) $132.20
- Advisor Catheter (Device) $130.05
- CARTO 3 (Device) $129.52
- XARELTO (Drug) $125.00
- AFX (Device) $108.89
- WATCHMAN (Device) $81.45
- CRT Leads (Device) $73.96
- Advisa (Device) $53.09
- Confirm Rx (Device) $39.02
- GENERAL - THERAPIES (Device) $28.11
- Thermocool (Device) $26.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Rochester
Samuel Asirvatham, M.d, M.D
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Srijoy Mahapatra, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Amir Lerman, M.d, M.D
Cardiovascular Disease — Payments: $590,259
Cardiovascular Disease $590,259
Charanjit Rihal, M.d, M.D
Cardiovascular Disease — Payments: $484,688
Cardiovascular Disease $484,688
Martha Grogan, M.d, M.D
Cardiovascular Disease — Payments: $402,326
Cardiovascular Disease $402,326
David Hayes, M.d, M.D
Cardiovascular Disease — Payments: $278,959
Cardiovascular Disease $278,959